WO2017114676A1 - A medical implant & methods of making same - Google Patents

A medical implant & methods of making same Download PDF

Info

Publication number
WO2017114676A1
WO2017114676A1 PCT/EP2016/081672 EP2016081672W WO2017114676A1 WO 2017114676 A1 WO2017114676 A1 WO 2017114676A1 EP 2016081672 W EP2016081672 W EP 2016081672W WO 2017114676 A1 WO2017114676 A1 WO 2017114676A1
Authority
WO
WIPO (PCT)
Prior art keywords
super hard
medical implant
grains
volume
forming
Prior art date
Application number
PCT/EP2016/081672
Other languages
French (fr)
Inventor
Valentine KANYANTA
Miriam MIRANDA-FERNANDEZ
Jonee Christine Paredes ZUNEGA
Xiaoxue ZHANG
Mehmet Serdar Ozbayraktar
Original Assignee
Element Six (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Element Six (Uk) Limited filed Critical Element Six (Uk) Limited
Publication of WO2017114676A1 publication Critical patent/WO2017114676A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/303Carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/08Carbon ; Graphite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/422Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/427Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of other specific inorganic materials not covered by A61L27/422 or A61L27/425
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/515Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics
    • C04B35/52Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics based on carbon, e.g. graphite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/515Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics
    • C04B35/52Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics based on carbon, e.g. graphite
    • C04B35/528Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics based on carbon, e.g. graphite obtained from carbonaceous particles with or without other non-organic components
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/64Burning or sintering processes
    • C04B35/645Pressure sintering
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/0093Other features
    • C04B38/0096Pores with coated inner walls
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30016Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in hardness, e.g. Vickers, Shore, Brinell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30024Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in coefficient of friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30026Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in wear resistance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/02Methods for coating medical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/04Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/06Coatings containing a mixture of two or more compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/05Preparation or purification of carbon not covered by groups C01B32/15, C01B32/20, C01B32/25, C01B32/30
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/25Diamond
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3217Aluminum oxide or oxide forming salts thereof, e.g. bauxite, alpha-alumina
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/42Non metallic elements added as constituents or additives, e.g. sulfur, phosphor, selenium or tellurium
    • C04B2235/422Carbon
    • C04B2235/427Diamond
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/50Constituents or additives of the starting mixture chosen for their shape or used because of their shape or their physical appearance
    • C04B2235/54Particle size related information
    • C04B2235/5418Particle size related information expressed by the size of the particles or aggregates thereof
    • C04B2235/5436Particle size related information expressed by the size of the particles or aggregates thereof micrometer sized, i.e. from 1 to 100 micron
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/50Constituents or additives of the starting mixture chosen for their shape or used because of their shape or their physical appearance
    • C04B2235/54Particle size related information
    • C04B2235/5418Particle size related information expressed by the size of the particles or aggregates thereof
    • C04B2235/5445Particle size related information expressed by the size of the particles or aggregates thereof submicron sized, i.e. from 0,1 to 1 micron
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/60Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
    • C04B2235/616Liquid infiltration of green bodies or pre-forms

Definitions

  • This disclosure relates to a medical implant comprising a structure formed of super hard material, particularly but not exclusively a structure comprising polycrystalline diamond (PCD) and a method of making same.
  • PCD polycrystalline diamond
  • DLC diamond-like carbon
  • Such coatings may be deposited from carbonaceous precursors, and some offer the means to incorporate other elements such as nitrogen, titanium, or silver.
  • the DLC must be deposited onto highly polished surfaces and DLC coatings may be susceptible to possible delamination of the coating from its substrate during use which could cause serious medical complications.
  • DLC has proved to be an excellent coating to prolong the life of and reduce complications associated with replacement hip joints and artificial knees, ever increasing drives for improved working life with improved abrasion and impact resistance are desired, as is a method of forming such constructions.
  • a medical implant comprising a structure formed of super hard material, the structure having porosity greater than 20% by volume and up to around 80% by volume.
  • a body joint prosthesis comprising one or more elements formed of the medical implant defined above.
  • a method of forming a medical implant comprising: forming a skeleton structure of a first material, the skeleton structure having a plurality of voids; at least partially filling some or all of the voids in the skeleton structure with a second material to form a pre-sinter assembly; wherein one or other of the first material or the second material comprises grains of super hard material; and treating the pre-sinter assembly at an ultra-high pressure of around 5 GPa or greater and a temperature to sinter together the grains of super hard material to form a body of polycrystalline super hard material comprising a first region of super hard grains, and an interpenetrating second region; the second region being formed of the other of the first or second material that does not comprise the super hard grains; the super hard grains forming a sintered medical implant structure of super hard material having a porosity greater than 20% by volume and up to around 80% by volume.
  • Figure 1 is a parts exploded view of a conventional hip-joint prosthesis
  • Figure 2 is a schematic cross-section through a hip-joint prosthesis according to a first example
  • Figure 3 is a schematic cross-section through a hip-joint prosthesis according to a second example
  • Figure 4 is a schematic cross-sectional view of the microstructure of conventional PCD material
  • Figure 5 is a plan view of a pre-sinter composite assembly of a material according to an example
  • Figure 6 is a plan view of a representation of a microstructure of an example composite suitable for use in the prosthesis of Figures 1 to 3;
  • Figure 7 is a perspective view from above and enlarged cross-sectional view through a portion of the microstructure of a material suitable for use in the prosthesis of Figures 2 and 3 according to a further example;
  • Figures 8a and 8b are cross-sectional views of a portion of the microstructure of a material according to a further example.
  • FIG 1 shows a typical conventional hip prosthesis 1 comprising a leg component 2 which is inserted into the patient's femur and comprises a stem portion 10, and a head portion12 attached thereto which is typically in the form of a truncated sphere with a partially extending through-bore 14 into which one end of the stem portion is located.
  • the hip component 1 6 comprises a dome-shaped liner element 18 which covers a portion of the head portion 12 and a shell 20 which is also dome shaped and is located on and over the liner element 18.
  • Figure 2 is a schematic cross-section through an assembled portion of the prosthesis of Figure 1 showing the shell 20 and liner element 18 located on the head portion 12.
  • a prosthetic joint such as a hip joint as shown in Figures 1 and 2
  • the surfaces between the head portion 12 and liner element 18 suffer significant wear from the rubbing effect during limb movements such as walking. Wear debris may have significant detrimental implications on a patient's health. For example, if such parts were formed of metal, metal debris in form of free metal ions may be absorbed by the body and lead to severe long-term complications. In addition, accelerated wear of the head 12 and liner 18 surfaces shortens the life span of the implant, meaning the patient would potentially go through several surgical operations in his/her life time. If ceramic parts are used they may not have the necessary fracture resistance and may suffer for sudden fractures.
  • any one or more of the shell 20, liner element 18 and head portion 12 may be formed of a material according to the examples described below, or that, as shown in Figure 3, any one or more of these components may have all or part of a surface coated with such a material or a layer of such a material bonded thereto.
  • the outer surface of the head portion 12 may be coated with a material according to an example, the coating forming a layer 22 over the head portion 12 and bonded thereto, the head portion 12 may itself be formed of a conventional material.
  • the surface 24 of the liner element 18 that abuts or contacts the head portion in use may be formed of or coated with a material according to an example, or have a layer of such a material bonded thereto.
  • a functionally graded structure may be employed with the example composite materials only forming a layer adjacent to the mating surfaces as shown in Figure 3. This may also be used to facilitate applications of coatings on the mating surfaces if required.
  • Some examples propose using a material with 3D continuously interpenetrating networks of PCD and metal or ceramic or a combination thereof.
  • a material with 3D continuously interpenetrating networks of PCD and metal or ceramic or a combination thereof may offer the high abrasion resistance of diamond and combine it with the fracture resistance of a metal or an engineered ceramic.
  • Diamond also has a lower coefficient of friction and is biostable and biocompatible, which add to the benefits of using such composite material in these applications.
  • the method of making PCD-ceramic and PCD-metal 3D interpenetrating material composites is discussed below.
  • a "super hard material” is a material having a Vickers hardness of at least about 28 GPa.
  • Diamond and cubic boron nitride (cBN) material are examples of super hard materials.
  • a "super hard construction” means a construction comprising a body of polycrystalline super hard material.
  • a substrate may be attached thereto or alternatively the body of polycrystalline material may be freestanding and unbacked.
  • polycrystalline diamond is a type of polycrystalline super hard (PCS) material comprising a mass of diamond grains, a substantial portion of which are directly inter-bonded with each other and in which the content of diamond is at least about 80 volume percent of the material.
  • interstices or "interstitial regions” are regions between the diamond grains of PCD material.
  • interstices between the diamond grains may be at least partly filled with a binder material comprising a catalyst for diamond.
  • interstices or interstitial regions may be substantially or partially filled with a material other than diamond, or they may be substantially empty.
  • PCD material may comprise at least a region from which catalyst material has been removed from the interstices, leaving interstitial voids between the diamond grains.
  • a "catalyst material" for a super hard material is capable of promoting the growth or sintering of the super hard material.
  • substrate as used herein means any substrate over which the super hard material layer is formed.
  • a “substrate” as used herein may be a transition layer formed over another substrate.
  • integrally formed regions or parts are produced contiguous with each other and are not separated by a different kind of material.
  • the micro-structure of a conventional PCD material is shown in Figure 4.
  • the diamond grains are directly interbonded to adjacent grains and the interstices 32 between the grains 34 of super hard material such as diamond grains in the case of PCD, may be at least partly filled with a non-super hard phase material.
  • This non-super hard phase material also known as a filler material, may comprise residual catalyst/binder material, for example cobalt, nickel or iron.
  • the typical average grain size of the diamond grains 34 is larger than 1 micron and the grain boundaries between adjacent grains is therefore typically between micron-sized diamond grains, as shown in Figure 4.
  • PCD Polycrystalline diamond
  • PCD material is an example of a super hard material (also called a super abrasive material or ultra hard material) comprising a mass of substantially inter- grown diamond grains, forming a skeletal mass defining interstices between the diamond grains.
  • PCD material typically comprises at least about 80 volume % of diamond and is conventionally made by subjecting an aggregated mass of diamond grains to an ultra-high pressure of greater than about 5 GPa, and temperature of at least about 1 ,200°C, for example.
  • a material wholly or partly filling the interstices may be referred to as filler or binder material.
  • PCD is typically formed in the presence of a sintering aid such as cobalt, which promotes the inter-growth of diamond grains.
  • a sintering aid such as cobalt
  • Suitable sintering aids for PCD are also commonly referred to as a solvent-catalyst material for diamond, owing to their function of dissolving, to some extent, the diamond and catalysing its re-precipitation.
  • a solvent-catalyst for diamond is understood be a material that is capable of promoting the growth of diamond or the direct diamond-to-diamond inter-growth between diamond grains at a pressure and temperature condition at which diamond is thermodynamically stable. Consequently the interstices within the sintered PCD product may be wholly or partially filled with residual solvent-catalyst material. Materials that do not promote substantial coherent intergrowth between the diamond grains may themselves form strong bonds with diamond grains, but are not suitable solvent - catalysts for PCD sintering.
  • a first example of a composite material for use either to form one or more components of a prosthesis or other implant for biomedical applications or for use as a coating or layer bonded to such components is described with reference to Figures 5 to 8b.
  • the examples of such a composite material comprise a three dimensionally (3D) continuous interpenetrating network of sintered inter-bonded polycrystalline super hard material 40 such as PCD, and one or more phases 42 comprising materials such as a ceramic, a metal alloy, hardmetals and/or polymers.
  • all respective phases, except the catalyst used for sintering the super hard material are continuous in three dimensions.
  • the super hard material 40 forms at least 10% of the composite by volume and up to around 80 % of the composite by volume.
  • the other phases 42 fill the remaining volume fraction.
  • the secondary phases may also be chemically removed after the composite is manufactured to form a porous super hard structure, with porosity greater than 20% by volume and up to around 80% by volume.
  • a porous super hard structure may be particularly suitable for use as a scaffold or skeleton structure for tissue regeneration as the tissue material may grow through the pores in the porous structure and in the example of a hip prosthesis,, may find particular application as the material for forming the shell 20.
  • alumina foam 42 as shown in Figure 5 was infiltrated with a plurality of diamond particles having an average particle size of around 15 microns.
  • diamond particles were added on top of the foam inside a niobium cup and the assembly was subjected to mechanical vibration in order to force the diamond particles to fill the pores inside the foam.
  • a slurry of diamond particles was formed and poured on top of the foam in order to fill the pores. The assembly was then allowed to settle and dry.
  • a tungsten carbide substrate with 13wt% cobalt was placed on top of the diamond infiltrated alumina foam inside a niobium cup to form a pre-composite assembly.
  • the pre-composite is then sintered at a pressure above 5GPa and temperature of about 1400°C in the presence of cobalt infiltrated from the WC-Co substrate.
  • This forms an intergrown (interbonded) PCD skeleton 40 with a three dimensionally continuously interpenetrating structure of alumina 42.
  • the WC substrate may be removed from the sintered structure by conventional methods such as EDM, or laser cutting techniques.
  • a PCD-titanium 3D continuously interpenetrating was formed by initially forming a titanium metal skeleton using 3D laser sintering of titanium powder.
  • the skeleton was introduced into a niobium cup and diamond powder added to fill the pores in the titanium skeleton.
  • a bimodal diamond powder was used comprising around 15wt% of diamond particles having an average grain size of around 2 microns and 85wt% of diamond particles having an average grain size of around 22 microns.
  • a tungsten carbide substrate with 13wt% cobalt was then added and the assembly was subjected to mechanical vibration to ensure the loose powders fill the empty spaces in the titanium skeleton.
  • the pre-composite was then sintered at a pressure above 5GPa and temperature of about 1400°C in the presence of cobalt infiltrated from the WC-Co substrate to form an interbonded PCD skeleton with a three dimensionally continuously interpenetrating structure of titanium.
  • the process of making a PCD-Ceramic and PCD-Metal 3D continuously interpenetrating composite starts with forming a porous ceramic or metal and then infiltrating it with diamond.
  • a porous diamond green body may be prepared via conventional freeze casting techniques or other manufacturing methods such as injection moulding, 3D inkjet or laser printing and robocasting.
  • the porous green body is then infiltrated with a second phase such as a ceramic, a metal, a polymer or a combination thereof and the product sintered as described above with respect to examples 1 and 2.
  • An alternative source of catalyst material for the PCD other than a WC substrate may be used in one or more examples such as admixing the catalyst such as Co into the diamond grains prior to sintering.
  • a 3D interpenetrating network of PCD and metal of polymer or any leachable material is prepared via any of the examples 1 to 3 described above.
  • the secondary phase(s) 42 namely any one or more of a metal, a polymer or any other leachable material are then removed via conventional chemical leaching techniques or any other suitable method to form a porous intergrown PCD structure.
  • This porosity is not less than 20% by volume of the PCD body and may be up to around 80% by volume of the PCD body.
  • PCD-Ceramic-Metal composites with three dimensionally (3D) continuous interpenetrating networks may exploit the superior tribological and mechanical properties, and biocompatibility of intergrown polycrystalline diamond.
  • the wear resistance may be significantly improved whilst at the same time the likelihood of allergic reactions caused by elements of these metals may be reduced.
  • the wear resistance and biocompatibility may be further improved, together with the fracture toughness.
  • Diamond also has a very low coefficient of friction.
  • diamond is an ideal material for biomedical applications, in particular as a medical implant manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure, such as hip and knee prostheses, due to the superior tribological and mechanical properties of diamond as well as good corrosion resistance, biocompatibility, and biostability.
  • second phase material 42 which may be used include but are not limited to TieAUV which has been proven to be biocompatible and has good biostability, and other metal alloys with similar properties, such as cobalt-chrome.
  • the PCD-Metal composite structure may be formed with a thin CVD diamond layer adhered to the free surface which may assist in inhibiting any residual catalyst material elements used in the sintering of the PCD being absorbed by the body.
  • the PCD material may be sintered for a period in the range from about 1 minute to about 30 minutes, about 2 minutes to about 15 minutes, or from about 2 minutes to about 10 minutes.
  • the sintering temperature may be in the range from about 1 ,200 degrees centigrade to about 2,300 degrees centigrade, about 1 ,400 degrees centigrade to about 2,000 degrees centigrade, about 1 ,450 degrees centigrade to about 1 ,700 degrees centigrade, or about 1 ,450 degrees centigrade to about 1 ,650 degrees centigrade.
  • a range of catalysing materials comprising metals and/or non- metals may be used.

Abstract

A medical implant comprises a structure formed of super hard material having porosity greater than 20% by volume and up to around 80% by volume. A method of forming a medical implant comprises forming a skeleton structure of a first material, the skeleton structure having a plurality of voids; at least partially filling some or all of the voids in the skeleton structure with a second material to form a pre-sinter assembly; wherein one or other of the first material or the second material comprises grains of super hard material; and treating the pre-sinter assembly at an ultra-high pressure of around 5 GPa or greater and a temperature to sinter together the grains of super hard material to form a body of polycrystalline super hard material. The body of polycrystalline super hard material comprises a first region of super hard grains, and an interpenetrating second region; the second region being formed of the other of the first or second material that does not comprise the super hard grains; the super hard grains forming a sintered medical implant structure of super hard material having a porosity greater than 20% by volume and up to around 80% by volume.

Description

A MEDICAL IMPLANT & METHODS OF MAKING SAME
Field
This disclosure relates to a medical implant comprising a structure formed of super hard material, particularly but not exclusively a structure comprising polycrystalline diamond (PCD) and a method of making same.
Background
Traditionally, medical implants such as hip or knee replacement joints are made of metal alloys such as nickel, chrome and cobalt. However, these may cause allergic responses, due to bulk or trace elements. Ceramic materials are another group of materials increasingly being used in, for example, hip joint prostheses due to their wear resistance and biocompatibility properties. However, implants formed of such materials may suffer from sudden failures or fractures due to lack of toughness of the material. As an alternative to ceramic materials, diamond-like carbon (DLC) coatings have also been exploited in biomedical applications, as coatings on conventional prosthetic structures. These coatings are typically extremely hard, have low friction, are bio-inert and may also inhibit leaching of metallic ions into the body. Such coatings may be deposited from carbonaceous precursors, and some offer the means to incorporate other elements such as nitrogen, titanium, or silver. For optimum tribological performance, however, the DLC must be deposited onto highly polished surfaces and DLC coatings may be susceptible to possible delamination of the coating from its substrate during use which could cause serious medical complications. Whilst DLC has proved to be an excellent coating to prolong the life of and reduce complications associated with replacement hip joints and artificial knees, ever increasing drives for improved working life with improved abrasion and impact resistance are desired, as is a method of forming such constructions.
Summary
Viewed from a first aspect there is provided a medical implant comprising a structure formed of super hard material, the structure having porosity greater than 20% by volume and up to around 80% by volume. l Viewed from a second aspect there is provided a body joint prosthesis comprising one or more elements formed of the medical implant defined above.
Viewed from a third aspect there is provided a method of forming a medical implant comprising: forming a skeleton structure of a first material, the skeleton structure having a plurality of voids; at least partially filling some or all of the voids in the skeleton structure with a second material to form a pre-sinter assembly; wherein one or other of the first material or the second material comprises grains of super hard material; and treating the pre-sinter assembly at an ultra-high pressure of around 5 GPa or greater and a temperature to sinter together the grains of super hard material to form a body of polycrystalline super hard material comprising a first region of super hard grains, and an interpenetrating second region; the second region being formed of the other of the first or second material that does not comprise the super hard grains; the super hard grains forming a sintered medical implant structure of super hard material having a porosity greater than 20% by volume and up to around 80% by volume.
Brief Description of the Drawings
Various versions will now be described by way of example and with reference to the accompanying drawings in which:
Figure 1 is a parts exploded view of a conventional hip-joint prosthesis;
Figure 2 is a schematic cross-section through a hip-joint prosthesis according to a first example;
Figure 3 is a schematic cross-section through a hip-joint prosthesis according to a second example;
Figure 4 is a schematic cross-sectional view of the microstructure of conventional PCD material; Figure 5 is a plan view of a pre-sinter composite assembly of a material according to an example;
Figure 6 is a plan view of a representation of a microstructure of an example composite suitable for use in the prosthesis of Figures 1 to 3;
Figure 7 is a perspective view from above and enlarged cross-sectional view through a portion of the microstructure of a material suitable for use in the prosthesis of Figures 2 and 3 according to a further example; and
Figures 8a and 8b are cross-sectional views of a portion of the microstructure of a material according to a further example.
The same references refer to the same general features in all the drawings. Detailed Description
Figure 1 shows a typical conventional hip prosthesis 1 comprising a leg component 2 which is inserted into the patient's femur and comprises a stem portion 10, and a head portion12 attached thereto which is typically in the form of a truncated sphere with a partially extending through-bore 14 into which one end of the stem portion is located. The hip component 1 6 comprises a dome-shaped liner element 18 which covers a portion of the head portion 12 and a shell 20 which is also dome shaped and is located on and over the liner element 18.
Figure 2 is a schematic cross-section through an assembled portion of the prosthesis of Figure 1 showing the shell 20 and liner element 18 located on the head portion 12.
In a prosthetic joint such as a hip joint as shown in Figures 1 and 2, the surfaces between the head portion 12 and liner element 18 suffer significant wear from the rubbing effect during limb movements such as walking. Wear debris may have significant detrimental implications on a patient's health. For example, if such parts were formed of metal, metal debris in form of free metal ions may be absorbed by the body and lead to severe long-term complications. In addition, accelerated wear of the head 12 and liner 18 surfaces shortens the life span of the implant, meaning the patient would potentially go through several surgical operations in his/her life time. If ceramic parts are used they may not have the necessary fracture resistance and may suffer for sudden fractures.
To address and potentially ameliorate such issues, it is proposed that any one or more of the shell 20, liner element 18 and head portion 12 may be formed of a material according to the examples described below, or that, as shown in Figure 3, any one or more of these components may have all or part of a surface coated with such a material or a layer of such a material bonded thereto. As shown in Figure 3, the outer surface of the head portion 12 may be coated with a material according to an example, the coating forming a layer 22 over the head portion 12 and bonded thereto, the head portion 12 may itself be formed of a conventional material. Similarly, the surface 24 of the liner element 18 that abuts or contacts the head portion in use may be formed of or coated with a material according to an example, or have a layer of such a material bonded thereto. In this case, instead of the head portion 12 and liner element 18 being made of an example material, a functionally graded structure may be employed with the example composite materials only forming a layer adjacent to the mating surfaces as shown in Figure 3. This may also be used to facilitate applications of coatings on the mating surfaces if required.
Some examples propose using a material with 3D continuously interpenetrating networks of PCD and metal or ceramic or a combination thereof. Such a composite may offer the high abrasion resistance of diamond and combine it with the fracture resistance of a metal or an engineered ceramic. Diamond also has a lower coefficient of friction and is biostable and biocompatible, which add to the benefits of using such composite material in these applications. The method of making PCD-ceramic and PCD-metal 3D interpenetrating material composites is discussed below.
As used herein, a "super hard material" is a material having a Vickers hardness of at least about 28 GPa. Diamond and cubic boron nitride (cBN) material are examples of super hard materials.
As used herein, a "super hard construction" means a construction comprising a body of polycrystalline super hard material. In such a construction, a substrate may be attached thereto or alternatively the body of polycrystalline material may be freestanding and unbacked.
As used herein, polycrystalline diamond (PCD) is a type of polycrystalline super hard (PCS) material comprising a mass of diamond grains, a substantial portion of which are directly inter-bonded with each other and in which the content of diamond is at least about 80 volume percent of the material. As used herein, "interstices" or "interstitial regions" are regions between the diamond grains of PCD material. In some examples of PCD material, interstices between the diamond grains may be at least partly filled with a binder material comprising a catalyst for diamond. In some examples of PCD material, interstices or interstitial regions may be substantially or partially filled with a material other than diamond, or they may be substantially empty. PCD material may comprise at least a region from which catalyst material has been removed from the interstices, leaving interstitial voids between the diamond grains.
A "catalyst material" for a super hard material is capable of promoting the growth or sintering of the super hard material.
The term "substrate" as used herein means any substrate over which the super hard material layer is formed. For example, a "substrate" as used herein may be a transition layer formed over another substrate.
As used herein, the term "integrally formed" regions or parts are produced contiguous with each other and are not separated by a different kind of material.
The micro-structure of a conventional PCD material is shown in Figure 4. During formation of a conventional polycrystalline diamond construction, the diamond grains are directly interbonded to adjacent grains and the interstices 32 between the grains 34 of super hard material such as diamond grains in the case of PCD, may be at least partly filled with a non-super hard phase material. This non-super hard phase material, also known as a filler material, may comprise residual catalyst/binder material, for example cobalt, nickel or iron. The typical average grain size of the diamond grains 34 is larger than 1 micron and the grain boundaries between adjacent grains is therefore typically between micron-sized diamond grains, as shown in Figure 4. Polycrystalline diamond (PCD) is an example of a super hard material (also called a super abrasive material or ultra hard material) comprising a mass of substantially inter- grown diamond grains, forming a skeletal mass defining interstices between the diamond grains. PCD material typically comprises at least about 80 volume % of diamond and is conventionally made by subjecting an aggregated mass of diamond grains to an ultra-high pressure of greater than about 5 GPa, and temperature of at least about 1 ,200°C, for example. A material wholly or partly filling the interstices may be referred to as filler or binder material.
PCD is typically formed in the presence of a sintering aid such as cobalt, which promotes the inter-growth of diamond grains. Suitable sintering aids for PCD are also commonly referred to as a solvent-catalyst material for diamond, owing to their function of dissolving, to some extent, the diamond and catalysing its re-precipitation. A solvent-catalyst for diamond is understood be a material that is capable of promoting the growth of diamond or the direct diamond-to-diamond inter-growth between diamond grains at a pressure and temperature condition at which diamond is thermodynamically stable. Consequently the interstices within the sintered PCD product may be wholly or partially filled with residual solvent-catalyst material. Materials that do not promote substantial coherent intergrowth between the diamond grains may themselves form strong bonds with diamond grains, but are not suitable solvent - catalysts for PCD sintering.
A first example of a composite material for use either to form one or more components of a prosthesis or other implant for biomedical applications or for use as a coating or layer bonded to such components is described with reference to Figures 5 to 8b. The examples of such a composite material comprise a three dimensionally (3D) continuous interpenetrating network of sintered inter-bonded polycrystalline super hard material 40 such as PCD, and one or more phases 42 comprising materials such as a ceramic, a metal alloy, hardmetals and/or polymers. In some examples, all respective phases, except the catalyst used for sintering the super hard material, are continuous in three dimensions. The super hard material 40 forms at least 10% of the composite by volume and up to around 80 % of the composite by volume. The other phases 42 fill the remaining volume fraction. The secondary phases (such as any one or more of a ceramic, a metal alloy, a hardmetal and a polymer) may also be chemically removed after the composite is manufactured to form a porous super hard structure, with porosity greater than 20% by volume and up to around 80% by volume. Such a porous super hard structure may be particularly suitable for use as a scaffold or skeleton structure for tissue regeneration as the tissue material may grow through the pores in the porous structure and in the example of a hip prosthesis,, may find particular application as the material for forming the shell 20.
The construction and formation of examples of material as shown in Figures 5 to 8b are discussed in more detail below with reference to the following examples, which are not intended to be limiting.
Example 1 :
Commercially available alumina foam 42 as shown in Figure 5 was infiltrated with a plurality of diamond particles having an average particle size of around 15 microns. In one method, diamond particles were added on top of the foam inside a niobium cup and the assembly was subjected to mechanical vibration in order to force the diamond particles to fill the pores inside the foam. In another method, a slurry of diamond particles was formed and poured on top of the foam in order to fill the pores. The assembly was then allowed to settle and dry. A tungsten carbide substrate with 13wt% cobalt was placed on top of the diamond infiltrated alumina foam inside a niobium cup to form a pre-composite assembly. The pre-composite is then sintered at a pressure above 5GPa and temperature of about 1400°C in the presence of cobalt infiltrated from the WC-Co substrate. This forms an intergrown (interbonded) PCD skeleton 40 with a three dimensionally continuously interpenetrating structure of alumina 42. In some applications, depending on the end use, the WC substrate may be removed from the sintered structure by conventional methods such as EDM, or laser cutting techniques.
Example 2:
A PCD-titanium 3D continuously interpenetrating was formed by initially forming a titanium metal skeleton using 3D laser sintering of titanium powder. The skeleton was introduced into a niobium cup and diamond powder added to fill the pores in the titanium skeleton. In this case a bimodal diamond powder was used comprising around 15wt% of diamond particles having an average grain size of around 2 microns and 85wt% of diamond particles having an average grain size of around 22 microns. A tungsten carbide substrate with 13wt% cobalt was then added and the assembly was subjected to mechanical vibration to ensure the loose powders fill the empty spaces in the titanium skeleton. The pre-composite was then sintered at a pressure above 5GPa and temperature of about 1400°C in the presence of cobalt infiltrated from the WC-Co substrate to form an interbonded PCD skeleton with a three dimensionally continuously interpenetrating structure of titanium.
Example 3:
In the above described examples 1 and 2, the process of making a PCD-Ceramic and PCD-Metal 3D continuously interpenetrating composite starts with forming a porous ceramic or metal and then infiltrating it with diamond. However, one may also start by forming a porous diamond green body and then infiltrating it with ceramic, metal, polymer or a combination thereof. Diamond green bodies may be prepared via conventional freeze casting techniques or other manufacturing methods such as injection moulding, 3D inkjet or laser printing and robocasting. The porous green body is then infiltrated with a second phase such as a ceramic, a metal, a polymer or a combination thereof and the product sintered as described above with respect to examples 1 and 2. An alternative source of catalyst material for the PCD other than a WC substrate may be used in one or more examples such as admixing the catalyst such as Co into the diamond grains prior to sintering.
Example 4:
A 3D interpenetrating network of PCD and metal of polymer or any leachable material is prepared via any of the examples 1 to 3 described above. The secondary phase(s) 42, namely any one or more of a metal, a polymer or any other leachable material are then removed via conventional chemical leaching techniques or any other suitable method to form a porous intergrown PCD structure. This porosity is not less than 20% by volume of the PCD body and may be up to around 80% by volume of the PCD body.
Whilst not wishing to be bound by any theory, it is submitted that PCD-Ceramic-Metal composites with three dimensionally (3D) continuous interpenetrating networks may exploit the superior tribological and mechanical properties, and biocompatibility of intergrown polycrystalline diamond. By imbedding a PCD skeleton inside the metal alloys of any one or more of, for example, nickel, chrome, alumina, cobalt and titanium, the wear resistance may be significantly improved whilst at the same time the likelihood of allergic reactions caused by elements of these metals may be reduced. In the case of PCD-ceramic composite with interpenetrating networks, the wear resistance and biocompatibility may be further improved, together with the fracture toughness. Diamond also has a very low coefficient of friction. Thus diamond is an ideal material for biomedical applications, in particular as a medical implant manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure, such as hip and knee prostheses, due to the superior tribological and mechanical properties of diamond as well as good corrosion resistance, biocompatibility, and biostability.
Further examples of the second phase material 42 which may be used include but are not limited to TieAUV which has been proven to be biocompatible and has good biostability, and other metal alloys with similar properties, such as cobalt-chrome.
In other examples, the PCD-Metal composite structure may be formed with a thin CVD diamond layer adhered to the free surface which may assist in inhibiting any residual catalyst material elements used in the sintering of the PCD being absorbed by the body.
While various versions have been described with reference to a number of examples, those skilled in the art will understand that various changes may be made and equivalents may be substituted for elements thereof and that these examples are not intended to limit the particular examples or versions disclosed. For example, in some embodiments of the method, the PCD material may be sintered for a period in the range from about 1 minute to about 30 minutes, about 2 minutes to about 15 minutes, or from about 2 minutes to about 10 minutes.
In some examples of the method, the sintering temperature may be in the range from about 1 ,200 degrees centigrade to about 2,300 degrees centigrade, about 1 ,400 degrees centigrade to about 2,000 degrees centigrade, about 1 ,450 degrees centigrade to about 1 ,700 degrees centigrade, or about 1 ,450 degrees centigrade to about 1 ,650 degrees centigrade. Also, whilst it is conventional to sinter PCD using a catalyst such as cobalt, a range of catalysing materials comprising metals and/or non- metals may be used.

Claims

Claims
1 . A medical implant comprising a structure formed of super hard material, the structure having porosity greater than 20% by volume and up to around 80% by volume.
2. The medical implant of claim 1 , further comprising one or more secondary phases located in one or more pores in the structure.
3. The medical implant of claim 2 wherein the one or more secondary phases comprise any one or more of a ceramic, a metal alloy, a hardmetal, or a polymer.
4. The medical implant of claim 2 wherein the one or more secondary phases comprise any one or more of titanium, alumina, TieAUV, or an alloy of cobalt and chrome.
5. The medical implant of any one of claims 2 to 4 wherein the one or more secondary phases comprise an interpenetrating network through the super hard material.
6. The medical implant of claim 5, wherein the interpenetrating network is substantially continuous through the structure.
7. The medical implant of any one of the preceding claims, wherein the super hard material comprises polycrystalline diamond material.
8. The medical implant of any one of the preceding claims, wherein the super hard material forms at least 10% of the composite by volume and up to around 80 % of the structure by volume.
9. A body joint prosthesis comprising one or more elements formed of the medical implant of any one of the preceding claims.
10. A method of forming a medical implant comprising: forming a skeleton structure of a first material, the skeleton structure having a plurality of voids; at least partially filling some or all of the voids in the skeleton structure with a second material to form a pre-sinter assembly; wherein one or other of the first material or the second material comprises grains of super hard material; treating the pre-sinter assembly at an ultra-high pressure of around 5 GPa or greater and a temperature to sinter together the grains of super hard material to form a body of polycrystalline super hard material comprising a first region of super hard grains, and an interpenetrating second region; the second region being formed of the other of the first or second material that does not comprise the super hard grains; the super hard grains forming a sintered medical implant structure of super hard material having a porosity greater than 20% by volume and up to around 80% by volume.
1 1 . The method of claim 10, wherein the step of forming a skeleton structure of a first material comprises forming a skeleton structure comprising any one or more of a ceramic, a metal alloy, a hardmetal, or a polymer.
12. The method of claim 10, wherein one or other of the first material or second material comprises any one or more of titanium, alumina, Ti6AI4V, or an alloy of cobalt and chrome, and the other of the first or second material comprises diamond grains, the sintered super hard structure comprising polycrystalline diamond material.
13. The method of any one of claims 10 to 12, wherein the interpenetrating second region is substantially continuous through the structure.
14. The method of any one of claims 10 to 13, wherein the super hard material forms at least 10% of the composite by volume and up to around 80 % of the structure by volume.
15. The method of any one of claims 10 to 14, further comprising treating the sintered structure to remove at least a portion of the first or second material that does not comprise the super hard grains from the structure.
1 6. The method of claim 10, wherein the step of forming a skeleton structure of a first material comprises forming a skeleton structure from an alumina foam.
17. The method of claim 10, wherein the step of forming a skeleton structure of a first material comprises forming a skeleton structure from titanium powder.
18. A medical implant, substantially as hereinbefore described with reference to any one embodiment as that embodiment is illustrated in any one or more of the accompanying drawings.
19. A method of forming a medical implant, substantially as hereinbefore described with reference to any one embodiment as that embodiment is illustrated in any one or more of the accompanying drawings.
PCT/EP2016/081672 2015-12-31 2016-12-19 A medical implant & methods of making same WO2017114676A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1523173.1 2015-12-31
GBGB1523173.1A GB201523173D0 (en) 2015-12-31 2015-12-31 A medical implant & methods of making same

Publications (1)

Publication Number Publication Date
WO2017114676A1 true WO2017114676A1 (en) 2017-07-06

Family

ID=55406534

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/081672 WO2017114676A1 (en) 2015-12-31 2016-12-19 A medical implant & methods of making same

Country Status (2)

Country Link
GB (2) GB201523173D0 (en)
WO (1) WO2017114676A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158200A1 (en) * 1994-08-12 2005-07-21 Diamicron, Inc. Use of CoCrMo to augment biocompatibility in polycrystalline diamond compacts
US20090263643A1 (en) * 2005-04-07 2009-10-22 Gardinier Clayton F Use of sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
WO2015140230A1 (en) * 2014-03-18 2015-09-24 Element Six (Uk) Limited Superhard pcd constructions and methods of making same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005158A (en) * 1930-10-18 1935-06-18 Communications Patents Inc Combination radioreceiver and timepiece
US7494507B2 (en) * 2000-01-30 2009-02-24 Diamicron, Inc. Articulating diamond-surfaced spinal implants
US20040111159A1 (en) * 2000-01-30 2004-06-10 Diamicron, Inc. Modular bearing surfaces in prosthetic joints
US6497727B1 (en) * 2000-01-30 2002-12-24 Diamicron, Inc. Component for use in prosthetic hip, the component having a polycrystalline diamond articulation surface and a plurality of substrate layers
WO2001055476A1 (en) * 2000-01-30 2001-08-02 Diamicron, Inc. Methods for manufacturing a diamond prosthetic joint component

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158200A1 (en) * 1994-08-12 2005-07-21 Diamicron, Inc. Use of CoCrMo to augment biocompatibility in polycrystalline diamond compacts
US20090263643A1 (en) * 2005-04-07 2009-10-22 Gardinier Clayton F Use of sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
WO2015140230A1 (en) * 2014-03-18 2015-09-24 Element Six (Uk) Limited Superhard pcd constructions and methods of making same

Also Published As

Publication number Publication date
GB2546000B (en) 2019-06-12
GB201523173D0 (en) 2016-02-17
GB2546000A (en) 2017-07-05
GB201621554D0 (en) 2017-02-01

Similar Documents

Publication Publication Date Title
US7494507B2 (en) Articulating diamond-surfaced spinal implants
AU2011237440B2 (en) Use of Ti and Nb cemented TiC in prosthetic joints
JP4248787B2 (en) Parts for artificial joints with bearings and joint surfaces covered with diamonds
US6596225B1 (en) Methods for manufacturing a diamond prosthetic joint component
US6517583B1 (en) Prosthetic hip joint having a polycrystalline diamond compact articulation surface and a counter bearing surface
US6800095B1 (en) Diamond-surfaced femoral head for use in a prosthetic joint
US6290726B1 (en) Prosthetic hip joint having sintered polycrystalline diamond compact articulation surfaces
US6488715B1 (en) Diamond-surfaced cup for use in a prosthetic joint
US6425922B1 (en) Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface
CN101947149B (en) Artificial hip joint consisting of multilayer shell core composite structural components
US6676704B1 (en) Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6709463B1 (en) Prosthetic joint component having at least one solid polycrystalline diamond component
US6514289B1 (en) Diamond articulation surface for use in a prosthetic joint
US7678325B2 (en) Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US6410877B1 (en) Methods for shaping and finishing prosthetic joint components including polycrystalline diamond compacts
US20040199260A1 (en) Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
JP2004537370A (en) Surgical implant
US6494918B1 (en) Component for a prosthetic joint having a diamond load bearing and articulation surface
US20070208427A1 (en) Prosthesis for joint replacement
GB2546000B (en) A medical implant & methods of making same
Geamān THE CHARACTERISTICS OF CERAMICS USED IN ORTHOPEDIC IMPLANTS.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16823241

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16823241

Country of ref document: EP

Kind code of ref document: A1